Self-myofascial Release With Foam Roller in Patients With Hemophilic Ankle Arthropathy
1 settembre 2021 aggiornato da: Investigación en Hemofilia y Fisioterapia
Prospective and Multicenter Study to Assess the Safety and Effectiveness of a Physiotherapy Treatment Through Self-myofascial Release With Foam Roller in Patients With Hemophilic Ankle Arthropathy. A Randomized Clinical Trial.
Introduction: Hemophilic ankle arthropathy is manifested by degenerative functional alterations (deficit of muscle strength, mobility and proprioception) (intra-articular alterations) and chronic pain. Myofascial release techniques are used to treat soft tissue adhesions, relieve pain and reduce tissue sensitivity.
Design. A randomized clinical trial. Aimed: To evaluate the safety and effectiveness of a protocol by self-myofascial release with Foam Roller applied in patients with hemophilic ankle arthropathy.
Patients: 70 patients with ankle arthropathy will be recruited for inclusion in the study. Patients will be recruited in 5 centers, from different regions of Spain.
Intervention: Each session will last approximately 15 minutes, with five physiotherapy sessions per week for a period of 3 months. Patients will be evaluated at baseline, after the intervention, and after a follow-up period of 3 months. The treatment program includes 11 exercises that must be administered bilaterally. A mobile application will be developed where each patient will be able to observe the exercises to be carried out.
Measuring instruments and study variables: digital goniometer (ankle range of motion); visual analog scale and pressure algometer (joint pain); Haemophilia Joint Health Score (joint status); dynamometer assess (muscle strength); 6-Minute Walking test (functionality of lower limbs); Mobile device (Activity record); Finger-floor test (muscle flexibility). At the same time, the study will allow to determine joint bleeding caused by applied physiotherapy treatment.
Expected results: To demonstrate the safety of this Physiotherapy technique in patients with hemophilia. Likewise, an improvement in ankle pain, functionality and joint motion is expected.
Panoramica dello studio
Tipo di studio
Interventistico
Iscrizione (Effettivo)
58
Fase
- Non applicabile
Contatti e Sedi
Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.
Luoghi di studio
-
-
Comunity Of Madrid
-
Madrid, Comunity Of Madrid, Spagna, 28670
- Universidad Europea de Madrid
-
-
Criteri di partecipazione
I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.
Criteri di ammissibilità
Età idonea allo studio
Da 18 anni a 65 anni (Adulto, Adulto più anziano)
Accetta volontari sani
Sì
Sessi ammissibili allo studio
Maschio
Descrizione
Inclusion Criteria:
- Patients diagnosed with hemophilia A and B disease.
- Over 18 years.
- Diagnosed with hemophilic arthropathy of the ankle (by clinical assessment with the Hemophilia Joint Health Score).
- On prophylactic or on demand treatment with FVIII / FIX concentrates.
Exclusion Criteria:
- Patients without ambulation ability.
- Patients with inhibitors (antibodies to FVIII or FIX).
- Patients with neurological or cognitive alterations that impede the comprehension of the questionnaires and physical tests.
- Not signed the informed consent document.
Piano di studio
Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Separare
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Rilascio auto-miofasciale
Ogni sessione durerà circa 15 minuti, con cinque sessioni di fisioterapia che si svolgeranno in un periodo di 3 mesi.
Il protocollo di auto-rilascio miofasciale per gli arti inferiori con Foam Roller e Solid Ball Massage, adattato ai pazienti con artropatia emofilica della caviglia, includerà 11 esercizi che devono essere somministrati bilateralmente.
Verrà sviluppata un'applicazione mobile dove ogni paziente potrà osservare gli esercizi da svolgere.
|
The Self-Myofascial release protocol for the lower limbs using a Foam Roller will include: Self-Myofascial release of the plantar region using and Solid Ball Massage; release of the myofascial components of the back of the leg using a Foam Roller; release of the myofascial components of the anterior part of the leg using a Foam Roller; release of myofascial components of the hamstring region using a Foam Roller; release of the myofascial components of the adductor muscles using a Solid Ball Massage in a sitting position; release of the myofascial components of the abductor muscles using a Foam Roller in lateral decubitus; and release of the myofascial components of the pelvitrochanteric muscles using a Foam Roller in a sitting position.
|
|
Nessun intervento: Control
Patients included in the control group will not receive any physiotherapy intervention.
They will continue with their routine prior to the beginning of the study.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Change from baseline ankle joint pain after treatment and at 3 months
Lasso di tempo: Screening visit, within the first seven days after treatment and after three months follow-up visit
|
Visual analogic scale (VAS).
This scale will be used to evaluate the perception of joint pain, where ankle joint pain ranges from 0 to 10 points (no pain to maximum perceived pain).
|
Screening visit, within the first seven days after treatment and after three months follow-up visit
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Change from baseline ankle joint pain after treatment and at 3 months
Lasso di tempo: Screening visit, within the first seven days after treatment and after three months follow-up visit
|
Pressure algometer.
Measuring instrument used to evaluate pressure joint pain.
The instrument shall consist of a measuring device attached to a hard rubber tip 1.1 cm in diameter.
Its sphere shall be calibrated in kg/cm2 with divisions of 0.1 kg/cm2.
The pressure algometry methodology applied was based mainly on the study by Hogeweg.
Before taking the measurements, patients will be instructed to say "yes" as soon as pressure exerted by the algometer becomes slightly unpleasant.
The pressure algometer shall be kept perpendicular to the surface of the skin with the right hand, stabilizing the axis of the instrument using the thumb and index finger of the left hand.
The pressure shall be increased at a uniform rate of approximately 1 kg/cm2 per second.
As soon as the subject, according to the instructions, says "yes", the pressure will be stopped and the score will be noted.
|
Screening visit, within the first seven days after treatment and after three months follow-up visit
|
|
Change from baseline lower limb functionality after treatment and at 3 months
Lasso di tempo: Screening visit, within the first seven days after treatment and after three months follow-up visit
|
Hemophilia Joint Health Score (HJHS).
This measuring instrument will be used to evaluate the joint condition of knees, ankles, and elbows.
It includes 8 items (inflammation and its duration, pain, atrophy and muscle strength, crepitus, and reduced flexion and extension) ranging from 0 to 20 points per joint (the higher the score, the greater the joint deterioration).
|
Screening visit, within the first seven days after treatment and after three months follow-up visit
|
|
Change from baseline range of motion of ankle after treatment and at 3 months
Lasso di tempo: Screening visit, within the first seven days after treatment and after three months follow-up visit
|
Digital Goniometry Ankle ROM shall be measured using a digital goniometer.
The assessment can be made with the patient standing.
This measuring instrument allows more accurate measurements than those obtained with a universal plastic goniometer.
|
Screening visit, within the first seven days after treatment and after three months follow-up visit
|
|
Change from baseline muscle strength after treatment and at 3 months
Lasso di tempo: Screening visit, within the first seven days after treatment and after three months follow-up visit
|
Dynamometry.
The maximum isometric strength of the flexor and extensor muscles of the main joints affected in hemophilia (knees and ankles) will be evaluated on both limbs with a manual dynamometer using a mark test.
For this test, the rater needs to keep the dynamometer stationary while the patient exerts maximum force against it.
|
Screening visit, within the first seven days after treatment and after three months follow-up visit
|
|
Change from baseline muscle flexibility after treatment and at 3 months
Lasso di tempo: Screening visit, within the first seven days after treatment and after three months follow-up visit
|
Fingertip-to-Floor Test.
This test is used to assess the degree of flexibility of the posterior muscles of the lower limbs.
This value is calculated as the distance between the fingertip and the floor when maximum hip flexion with knee extension is performed.
|
Screening visit, within the first seven days after treatment and after three months follow-up visit
|
Collaboratori e investigatori
Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.
Pubblicazioni e link utili
La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.
Studiare le date dei record
Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.
Studia le date principali
Inizio studio (Effettivo)
2 febbraio 2020
Completamento primario (Effettivo)
26 giugno 2020
Completamento dello studio (Effettivo)
15 dicembre 2020
Date di iscrizione allo studio
Primo inviato
11 aprile 2019
Primo inviato che soddisfa i criteri di controllo qualità
11 aprile 2019
Primo Inserito (Effettivo)
16 aprile 2019
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
2 settembre 2021
Ultimo aggiornamento inviato che soddisfa i criteri QC
1 settembre 2021
Ultimo verificato
1 settembre 2021
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- He-Foam
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
NO
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
No
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
No
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .